AT cells were transfected with a constitutively active HRAS gene, but these types of mutations are rare in human breast cancer, where specific genetic polymorphisms [42,43] and higher expression levels [44,45] are more prevalent. The gene discussed is HRAS; the disease is breast carcinoma.